View in EDS HTML Full Text PDF Full Text

Limited Clinical Benefit of Immune Checkpoint Inhibition in Ovarian Cancer with Opportunities in Selected Subtypes.

Saved in:
Bibliographic Details
Title: Limited Clinical Benefit of Immune Checkpoint Inhibition in Ovarian Cancer with Opportunities in Selected Subtypes.
Authors: Ratka, Zuzanna1 (AUTHOR), Gamian, Andrzej2 (AUTHOR), Woźniak, Marta1 (AUTHOR) marta.wozniak@umw.edu.pl
Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4923. 26p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms27114923